Posts for Ticker ‘WIN’

Early Bird Analyst Upgrades & Downgrades (CPHD, SCHW, DSX, GYMB, WIN, AMED, EGLE, NMM, SOL, PAY)

Money_stack_picThese are some of the top early bird analyst upgrades and downgrades we are seeing this Thursday morning:

  • Cepheid (CPHD) Started as Buy at Needham.
  • Charles Schwab (SCHW) Raised to Market Perform at FBR.
  • Diana Shipping (DSX) Raised to Overweight at JPMorgan.
  • Gymboree (GYMB) Raised to Overweight at JPMorgan.
  • Windstream (WIN) Raised to Overweight at JPMorgan.
  • AMEDISYS (AMED) Cut to Hold at Deutsche Bank.
  • Eagle Bulk Shipping (EGLE) Cut to Underweight at JPMorgan.
  • Navios Maritime Partners (NMM) Cut to Neutral at JPMorgan.
  • ReneSola Ltd. (SOL) Cut to Neutral at Credit Suisse.
  • Verifone (PAY) Cut to Underweight from overweight at JPMorgan.

Jon C. Ogg
November 20, 2008

Top 10 Pre-Market Analyst Calls (ADBE, CRUS, DVA, EEQ, EQR, IP, LNCR, RGLD, WIN, BRL, MFLX, MYL, TEVA, WPI)

These are not the only analyst impact calls, but these are the top research notes that 247WallSt.com is focusing on:

  • Adobe Systems (ADBE) raised to Buy at Deutsche Bank.
  • Cirrus Logic (CRUS) raised to Buy at Jefferies.
  • DaVita (DVA) raised to Buy at Oppenheimer.
  • Embarq (EQ) raised to Overweight at J.P.Morgan.
  • Equity Residential (EQR) raised to Overweight at Lehman.
  • International Paper (IP) raised to Outperform at Credit Suisse.
  • Lincare (LNCR) downgraded to Neutral at Oppenheimer.
  • Royal Gold (RGLD) raised to Overweight at HSBC.
  • Windstream (WIN) downgraded to Underweight at J.P.Morgan.
  • BANC OF AMERICA ON DRUGS: Barr Pharma (BRL) started as Buy; Multi-Fineline (MFLX) started as Buy; Mylan Labs (MYL) started as Buy; Teva Pharma (TEVA) started as Buy; Watson Pharma (WPI) started as neutral; ZymoGenetics (ZGEN) downgraded to Neutral.

Jon C. Ogg
December 18, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.

Earlybird Analyst Calls (June 14, 2007)

ACL started as Buy at Jefferies.
AMGN started as Mkt Perform at Rodman & Renshaw.
B started as Outperform at CIBC.
CBB started as Buy at UBS.
CHE started as Buy at Jefferies.
CTL raised to Neutral at UBS.
CYTX started as Mkt Perform at Piper Jaffray.
DJ cut to Reduce at UBS.
EQ raised to Buy at UBS.
ESI cut to Equal Weight at Lehman.
EYE started as Underperform at Jefferies.
GNLB started as Buy at Oppenheimer.
ILMN raised to Outperform at Bear Stearns.
ISIL raised to Buy at B of A.
MFA started as Outperform at JMP Securities.
MNKD started as Buy at B of A.
OPTT started as Outperform at Bear Stearns.
PT raised to Outperform at Credit Suisse.
RACK started as Buy at Merriman Curhan Ford.
RBC started as Sector Perform at CIBC.
SLM cut to Peer Perform at Bear Stearns.
SNY cut to Neutral at HSBC; cut to Neutral at JPMorgan.
THI raised to Outperform at CIBC.
VDSI cut to Hold at Jefferies.
VTIV raised to Strong Buy at First Albany.
WIN started as Neutral at UBS.
ZGEN started as Neutral at Oppenheimer.

Jon C. Ogg
June 14, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.